Pharmaceutical Products

AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen·Dresden, Germany·Deadline Aug 31, 2028 · 665 days left·Open·Supplies

Structured notice only

Original notice title

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

53/100

Opportunity Score

Needs reviewMedium complexity

SuppliesOpen

Why this score?

Opportunity

53 / 100

Complexity

62 / 100

Risk factors

Demand depends on insurance membership, prescribing behaviour, pharmacy dispensing and stocking behaviour, and other ma...

The authority may end the Open-House process early, particularly after exclusive rebate agreements are concluded; exist...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Tender facts

Contracting authority: AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen
Country: Germany
CPV: 33600000 - Pharmaceutical products
Deadline: Aug 31, 2028

Overview

Moderate opportunity

Key Facts

Supplies contract
1 lot
Duration until Aug 2028
Supply of pharmaceutical products covered by non-exclusive rebate agreements for Orylmyte(R) (ATC code V01AA03), including relevant parallel and re-imported products.
The arrangement applies in Germany, with the structured place of performance identified as Dresden; the XML notice additionally describes the geographic scope as Germany and the federal states of Saxony and Thuringia.

Show full summary

Open-House framework-style arrangement for non-exclusive pharmaceutical rebate agreements covering Orylmyte(R) (ATC V01AA03), including parallel and re-imported products, for AOK PLUS. Participation is open during the stated period to pharmaceutical companies that satisfy and accept the fixed conditions. No individual negotiations or delivery exclusivity apply, and demand and minimum quantities are not guaranteed. The participation documents and rebate terms were not provided for analysis.

Risks

Demand depends on insurance membership, prescribing behaviour, pharmacy dispensing and stocking behaviour, and other ma...

The authority may end the Open-House process early, particularly after exclusive rebate agreements are concluded; exist...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

Participation is limited to pharmaceutical entrepreneurs within the meaning of § 4(18) AMG for the offered medicinal products.
A pharmaceutical entrepreneur must have its registered seat within the scope of the AMG, another EU Member State, or another EEA contracting state for medicinal products within...
Local representatives may participate only if they themselves qualify as pharmaceutical entrepreneurs for the relevant products.

Requirements may be incomplete.

Buyer

Name

AOK PLUS - Die Gesundheitskasse für Sachsen und Thürigen

Location

Dresden, DEU

[email protected]

Website

www.aok.de/pk/plus/

Buyer profile

Open profile

Identifier

DE256878834

Activity

Health

Lots (1)

LOT-0001

Orylmyte(R) Pharmaceutical Rebate Agreement

Non-exclusive rebate agreement under § 130a(8) SGB V through an Open-House model for Orylmyte(R), including parallel and re-imported products. Contracting may occur during the participation period, with no guaranteed minimum purchase quantity and possible early termination if exclusive rebate agreements are concluded.

SuppliesFrameworkEU fundedElectronic submission

Location

Dresden, Germany

Duration

Aug 2026 - Aug 2028